| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,290 | 1,375 | 16:36 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.07. | Mentice AB: Mentice Growth Trajectory Continues In Q2 2026 | 209 | GlobeNewswire (Europe) | SIGNIFICANT EVENTS DURING THE SECOND QUARTER 2026 (APR - JUN)On June 29, Mentice announced the receipt of two orders with a total value of USD 2.4M from one of the top 20 global MedTech companies within... ► Artikel lesen | |
| 29.06. | Mentice AB: Mentice secures $2.4M in several orders from one Top 20 Global MedTech Company in Interventional Cardiology, focused on Structural Heart Disease | 468 | GlobeNewswire (Europe) | Mentice AB (publ), a globally recognized leader in simulation solutions for image-guided therapies, today announced the receipt of two orders in total value of $2.4M from one of the world's top 20 medical... ► Artikel lesen | |
| 01.06. | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | 927 | GlobeNewswire (Europe) | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| 07.05. | Mentice AB: Interim Report Jan-mar 2026 | 291 | GlobeNewswire (Europe) | CONTINUED MOMENTUM AND STRONG ORGANIC GROWTH
Significant events during the FIRST quarter 2026 (JAN - MAR)Order intake and revenues increased significantly during the quarter and Order Intake amounted... ► Artikel lesen | |
| 23.03. | Mentice AB: Mentice Appoints Rick van Veen as Chief Financial Officer and Announces Changes to the Executive Management Group | 219 | GlobeNewswire (Europe) | Mentice AB (publ), Gothenburg, Sweden - Mentice today announced the appointment of Rick van Veen as Chief Financial Officer, effective July 1, 2026. Rick brings extensive experience in financial management... ► Artikel lesen | |
| 26.02. | Mentice AB: Communique from extraordinary shareholders' meeting in Mentice AB | 241 | GlobeNewswire (Europe) | An extraordinary shareholders' meeting was held in Mentice AB ("the Company") on February 26, 2026. Below follows a summary of the resolutions made at the meeting.
Resolution on the number of board... ► Artikel lesen | |
| 26.02. | Mentice AB: Mentice publishes the company's year-end report for the period January-December 2025 | 255 | GlobeNewswire (Europe) | STRONG ORGANIC GROWTH AND RESULT IMPROVEMENT DESPITE CURRENCY HEADWINDS
SIGNIFICANT EVENTS DURING THE FOURTH QUARTER 2025 (OCT - DEC)Order intake increased significantly during the quarter and amounted... ► Artikel lesen | |
| 08.12.25 | Bure Equity AB: Bure divests holding in Mentice | 462 | GlobeNewswire (Europe) | Bure Equity AB (publ) ("Bure") has signed an agreement to divest 4,037,824 shares in Mentice AB (publ), listed on Nasdaq First North Growth Market.
The buyer is Gulf Offshore Limited, a company controlled... ► Artikel lesen | |
| MENTICE Aktie jetzt für 0€ handeln | |||||
| 06.11.25 | Mentice AB: Mentice publishes the company's interim report for the period July - September 2025 | 301 | GlobeNewswire (Europe) | SIGNIFICANT PROGRESS IN PERFORMANCE AS MARKET ACTIVITY INCREASES
SIGNIFICANT EVENTS DURING THE THIRD QUARTER 2025 (Jul - Sep)• The strategic organizational change announced in June, aimed at aligning... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,150 | +1,00 % | Eckert&Ziegler-Aktie im Check am 17.09. (08:16 Uhr): Meine aktuelle Lageeinschätzung | ||
| PENUMBRA | 278,20 | +0,07 % | Reasons to Retain Penumbra Stock in Your Portfolio for Now | ||
| FRESENIUS MEDICAL CARE | 39,170 | -2,15 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| FRESENIUS | 46,055 | -0,18 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 11:59... ► Artikel lesen | |
| AETHLON MEDICAL | 6,900 | +382,52 % | Morning Market Movers: AEMD, DAIC, LGVN, DLXY See Big Swings | OTTAWA (dpa-AFX) - At 8:50 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,590 | +0,60 % | BERENBERG stuft Siemens Healthineers auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Siemens Healthineers mit einem Kursziel von 40 Euro auf "Hold" belassen. Der Medizintechnik- und Life-Science-Sektor bleibe fundamental attraktiv... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 9,100 | +4,48 % | Alignment Healthcare extends retreat, falls an additional 16% | ||
| BETA BIONICS | 21,960 | -0,99 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,80 | -0,27 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| GENEDX | 101,29 | +3,91 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| CARL ZEISS MEDITEC | 29,600 | -2,31 % | EQS-DD: Carl Zeiss Meditec AG: Andreas Pecher, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 15:20... ► Artikel lesen | |
| ESSILORLUXOTTICA | 142,20 | -2,23 % | Wie kommt eine neue Brillentechnologie in einen 160-Milliarden-Dollar-Markt? Warum Vertrieb für kleine Health-Tech-Unternehmen zum entscheidenden Faktor wird | ||
| AVEANNA HEALTHCARE | 14,200 | -0,42 % | Aveanna Healthcare auf dem Deutsche Bank Healthcare Summit 2026: Neuausrichtung auf Wachstumskurs | ||
| HEARTFLOW | 49,570 | +2,57 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,000 | 0,00 % | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus |